What did @zygomatic_excellence actually say?
The transcript here is largely incoherent, likely garbled audio or an auto-caption failure. The clearest signal is the caption itself: "Nothing gear won't fix." That is the actual claim being made. "Gear" is gym-community slang for anabolic steroids or testosterone. The implied message is that exogenous testosterone, or anabolic compounds broadly, can resolve whatever problem you are facing physically or perhaps even mentally. That is a bold, sweeping claim, and it deserves direct scrutiny.
To be fair to the creator, the caption reads like a motivational quip, not a medical lecture. But with 39,000 views and TRT as the category, people are watching this through a clinical lens, and the framing matters. Casual sloganeering about hormone therapy can and does influence real decisions people make about their bodies.
Does the science back this up?
No, not broadly. Testosterone therapy has real, documented benefits for men with confirmed hypogonadism, but it is not a universal fix, and that distinction matters enormously. The TRAVERSE trial (Lincoff et al., 2023, New England Journal of Medicine) found that testosterone replacement in middle-aged men with hypogonadism did not significantly increase cardiovascular risk at moderate follow-up, which was reassuring. But that same trial was not a green light for open-ended use in healthy men chasing optimization.
On the performance and body composition side, a classic paper by Bhasin et al. (1996, NEJM) showed that supraphysiologic testosterone doses increased muscle mass even without exercise. That finding is real. But supraphysiologic is the operative word, and the doses used were well above what any legitimate TRT protocol delivers. Conflating TRT with anabolic steroid use, which the caption arguably does, misleads people about both the benefits and the risks.
- Testosterone does increase lean mass and reduce fat mass in hypogonadal men (Snyder et al., 2016, NEJM Testosterone Trials).
- It does not reliably fix depression, low energy, or poor sleep in eugonadal men with normal testosterone levels.
- Fertility suppression, erythrocytosis, and testicular atrophy are real, documented downsides that no slogan accounts for.
What did they get wrong (or right)?
The slogan gets something partially right: for men with clinically low testosterone, hormone therapy can be genuinely life-changing. The symptom burden of true hypogonadism, fatigue, low libido, loss of muscle mass, mood disruption, is well documented, and treatment works. The Testosterone Trials (Snyder et al., 2016) showed meaningful improvements in sexual function and some mood metrics in older hypogonadal men. Credit where it is due.
But "nothing gear won't fix" implies universality and zero downsides. That is where this falls apart. Exogenous testosterone suppresses the hypothalamic-pituitary-gonadal axis. That is not a minor footnote. For younger men, it can mean prolonged or permanent fertility impairment. Polycythemia, elevated hematocrit, and associated clotting risk are real adverse effects documented in multiple reviews (Calof et al., 2005, Journals of Gerontology). Sleep apnea worsens. Skin and prostate issues emerge. These are not rare edge cases.
The casual "gear fixes everything" framing also blurs the line between medically supervised TRT and unsupervised anabolic steroid use. Those are not the same thing, and presenting them as interchangeable is misleading to anyone watching.
What should you actually know?
If you are considering testosterone therapy because a TikTok caption made it sound like a clean fix, slow down. Start with bloodwork. Total testosterone, free testosterone, LH, FSH, SHBG, hematocrit, and a lipid panel give you an actual baseline. A single low reading in the morning is not sufficient for diagnosis. Clinical guidelines from the American Urological Association recommend at least two separate fasting morning measurements below 300 ng/dL before confirming hypogonadism.
Testosterone therapy is also not a decision to reverse easily. Once you start, your own production suppresses, sometimes significantly. Restart protocols exist, but recovery timelines vary widely and are not guaranteed, particularly after prolonged use. Men who want biological children should discuss this with a reproductive endocrinologist before starting any testosterone product.
Compounded testosterone formulations and FDA-approved brand-name products are not interchangeable. Dosing, absorption, and consistency can differ, and that matters for both efficacy and safety monitoring. Any platform, including this one, should be transparent about those distinctions rather than papering over them.